Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Multicenter Studies. Found 5 abstracts

Langer CJ. The global role of irinotecan in the treatment of lung cancer: 2003 update. Oncology (Huntingt). 2003 Jul;17(7 Suppl 7):30-40.
Michalski JM, Winter K, Purdy JA, Wilder RB, Perez CA, Roach M, Parliament MB, Pollack A, Markoe AM, Harms W, Sandler HM, Cox JD. Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II. Int J Radiat Oncol Biol Phys. 2003 May;56(1):192-8.
Giantonio BJ, Hochster H, Blum R, Wiernik PH, Hudes GR, Kirkwood J, Trump D, Oken MM. Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: a report of two clinical trials of the Eastern Cooperative Oncology Group. Invest New Drugs. 2001 Jan;19(1):89-92.
Obasaju C, Hudes GR. Paclitaxel and docetaxel in prostate cancer. Hematol Oncol Clin North Am. 2001 Jun;15(3):525-45.
Goldberg M, Unger M. Lung cancer. Diagnostic tools. Chest Surg Clin N Am. 2000 Nov;10(4):763-79, vii.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Multicenter Studies

Human Multicenter Studies Treatment Outcome Male Drug Administration Schedule drug therapy administration & dosage radiotherapy Middle Age Lung Neoplasms analogs & derivatives therapeutic use Phase II Clinical Trials Adjuvant Chemotherapy Prostatic Neoplasms Neoplasm Drug Resistance US Gov't Support-PHS derivatives Adult Aged Adenocarcinoma Survival Analysis Antineoplastic Combined Chemotherapy Protocols adverse effects Etoposide analogs & genetics Enzyme Inhibitors Rectum Proto-Oncogene Proteins c-bcl-2 Follow-Up Studies Estramustine Time Factors Palliative Care Severity of Illness Index Paclitaxel Thrombocytopenia Emission-Computed Tomography-Single-Photon etiology Mediastinoscopy Antisense Oligonucleotides Bladder drug effects cytology Three-Dimensional Imaging Organ Specificity adverse Mitoxantrone Radiotherapy Dosage Mitosis pharmacology Phase I Clinical Trials Interferon Inducers Randomized Controlled Trials Japan Lung Microtubules Camptothecin Renal Cell Carcinoma Carboxymethylcellulose effects Kidney Neoplasms Retrospective Studies Female Thoracic Radiography Needle Biopsy Fludeoxyglucose F 18 Phytogenic Antineoplastic Agents Dexamethasone United States Apoptosis radiation effects Neutropenia Posture Tumor Suppressor Genes Poly I-C Sputum Thoracoscopy Lymphoma X-Ray Computed Tomography Fluorescence bcl-2 Genes metabolism Bronchoalveolar Lavage Gastrointestinal Hemorrhage diagnosis Carboplatin Radiation Injuries chemically induced Quality of Life Phase III Clinical Trials Neoplasm Proteins Comparative Study Computer-Assisted Radiotherapy Planning Conformal Radiotherapy Cisplatin Antisense Oligodeoxyribonucleotides Polylysine diagnostic use Bronchoscopy radionuclide imaging Hydrocortisone Tubulin Signal Transduction Video-Assisted Thoracic Surgery Local Neoplasm Recurrence Clinical Trials pathology Neoplasm Staging Radiodermatitis Deoxycytidine Vindesine antagonists & inhibitors Post-Translational Protein Processing Radiopharmaceuticals Adjuvant Radiotherapy injuries Magnetic Resonance Imaging Emission-Computed Tomography
Last updated on Wednesday, March 04, 2020